Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
ESC Heart Failure|November 12, 2020
Clinical phenotypes, aetiologies, management, and mortality in acute heart failure: a single-institution study in Latin-AmericaHéctor González-Pacheco, Amada Álvarez-Sangabriel, Carlos Martínez-Sánchez, et al.
Frontiers in Cardiovascular Medicine|November 6, 2023
Analysis of immortal-time effect in post-infarction ventricular septal defectHéctor González-Pacheco, Jorge Arturo Ortega-Hernandez, Jesús Ángel Meza-López, et al.
Global Heart|December 13, 2021
Cardiogenic Shock Among Patients with and without Acute Myocardial Infarction in a Latin American Country: A Single-Institution StudyHéctor González-Pacheco, Daniel Manzur-Sandoval, Rodrigo Gopar-Nieto, et al.
Therapeutic Advances in Respiratory Disease|September 9, 2022
The prognostic importance of the angiotensin II/angiotensin-(1-7) ratio in patients with SARS-CoV-2 infectionLuis M Amezcua-Guerra, Leonardo Del Valle, Héctor González-Pacheco, et al.
International Journal of Cardiology. Congenital Heart Disease|December 23, 2024
Comparison in the adult congenital heart disease severity classification of ACC/AHA and ESC guidelines in a 3,459 Mexican populationEdgar García-Cruz, Montserrat Villalobos-Pedroza, Neftali Eduardo Antonio-Villa, et al.
Echocardiography (Mount Kisco, N.Y.)|August 31, 2020
Critical care ultrasonography during COVID-19 pandemic: The ORACLE protocolEdgar García-Cruz, Daniel Manzur-Sandoval, Rafael Rascón-Sabido, et al.
JACC. Advances|June 28, 2024
Cardiometabolic Risk Factors in Mexican Adults With Congenital Heart DiseaseEdgar García-Cruz, Daniel Manzur-Sandoval, Rodrigo Gopar-Nieto, et al.
CJC Pediatric and Congenital Heart Disease|November 16, 2023
Clinical Characteristics and Outcomes in Adults With Moderate-to-Severe Complexity Congenital Heart Disease Undergoing Palliation or Surgical RepairEdgar García-Cruz, Daniel Manzur-Sandoval, Rodrigo Gopar-Nieto, et al.
Molecular Medicine (Cambridge, Mass.)|November 8, 2022
Pyridostigmine reduces mortality of patients with severe SARS-CoV-2 infection: A phase 2/3 randomized controlled trialSergio Fragoso-Saavedra, Isaac Núñez, Belem M Audelo-Cruz, et al.
Pageof 6